drug · small molecule
patient view →orvepitant
Phase 2updated 2mo agoby NeRRe Therapeutics Ltd🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 4 investigational indications.
targets
Substance-P receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that